ARCHIVES

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Preyer Supported For Chairmanship

January 26, 1979

T-Cell Vaccines Cut Time To Protective Immunity

November 25, 2005

NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed

July 9, 1976

Statin Drugs May Prevent Breast Cancer, Lab Suggests

April 25, 2003

NCI Programs: Klausner Plans 20-25% Increase In Funding For Cooperative Groups

November 6, 1998

Ethics Commission To Continue Consideration Of Compensation For Injured Research Subjects

June 20, 1980